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Abstract B-cell chronic lymphocytic leukemia (B-CLL) is a
human hematological neoplastic disease often associated with the
loss of a chromosome 13 region between RB1 gene and locus
D13S25. A new tumor suppressor gene (TSG) may be located in
the region. A cosmid contig has been constructed between the loci
D13S1168 (WI9598) and D13S25 (H2-42), which corresponds to
the minimal region shared by B-CLL associated deletions. The
contig includes more than 200 LANL and ICRF cosmid clones
covering 620 kb. Three cDNAs likely corresponding to three
different genes have been found in the minimally deleted region,
sequenced and mapped against the contigged cosmids. cDNA
clone 10k4 as well as a chimeric clone 13g3, codes for a zinc-
finger domain of the RING type and shares homology to some
known genes involved in tumorigenesis (RET finger protein,
BRCA1) and embryogenesis (MID1). We have termed the gene
corresponding to 10k4/13g3 clones LEU5. This is the first gene
with homology to known TSGs which has been found in the
region of B-CLL rearrangements.
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1. Introduction
Genes that normally function to prevent or suppress malig-
nancy are known as ‘tumor suppressor genes’ or TSG [1]. The
¢rst example of a TSG in humans was the RB1 gene [2]. The
bi-allelic functional loss of this gene is associated with the
childhood neural retina tumor called retinoblastoma and the
gene itself is located on human chromosome 13q14.3. This
genomic region is also frequently lost in B-cell chronic lym-
phocytic leukemia (B-CLL), the most frequent hematopoetic
neoplastic disease in elderly [3,4]. B-CLL patients with 13q14
deletions were, however, found to retain a functional RB1
gene in the malignant cells. These observations indicated
that a defect of a gene telomeric to RB1 may be involved in
the malignant transformation of B cells [3^5]. The minimal
region shared by B-CLL associated deletions includes loci
D13S272 to D13S25 at the telomeric side [6^8]. According
to other data [9] the deletions expand from D13S272 in the
opposite direction to the D13S273 locus. Our recent data have
minimized the region of interest to a 130-kb area around the
locus D13S319 [10] and further down to an approximately 10-
kb region [11].
One strategy to discover the putative TSG gene involves a
¢ne mapping of the genomic region lost in leukocytes of B-
CLL patients, followed by screening of cDNA clones belong-
ing to this region and subsequent characterization of a prob-
able candidate TSG. LANL and ICRF chromosome 13 spe-
ci¢c cosmid libraries have been shown to be good sources to
construct such maps [12,13].
Previously a YAC-STS map of the region, frequently lost in
B-CLL [13,14], as well as a smaller contig with YAC derived
cosmids covering the region [10] has been constructed. A re-
cent map of the 13q14.3 region included 13 PAC clones, 42
cosmids and several EST markers without any homology to
known genes [15]. Here we describe a cosmid contig (based on
genomic libraries LANL and ICRF) covering the minimal
region shared by B-CLL-associated deletions, cDNA screen-
ing corresponding to YAC ICRF 61c1, as well as ¢ne map-
ping and sequencing of the cDNA clones. One of the cDNA
clones, 10k4, contains a zinc-¢nger domain and seems to be
an additional interesting candidate for being a B-CLL TSG.
2. Materials and methods
2.1. Chromosome 13 cosmid libraries
Two genomic chromosome 13-speci¢c cosmid libraries LA13NC01
and ICRF C108 (average size of insert 38 kb) have been characterized
in our previous work [12]. The cosmids subcloned from YACs have
been described in [10]. The subcloned cosmids were both included into
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the clone grid and used as probes but they are presented only in the
probe bar on Fig. 1. These subcloned cosmid names on Fig. 1 start
from a letter (‘a’, ‘b’ or ‘c’ for YAC ICRF 61c1, 126a9 and CEPH
922a8, respectively).
2.2. YAC clones
The CEPH and ICRF YAC clones and contig used to make the
cosmid contig and screen cDNA libraries have been described before
[14,16].
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Fig. 1. Cosmid contig between loci D13S1168 and D13S25. STS markers assigned to the cosmids are shown in the upper line. The next line
represents YAC structure. The YAC structure is shown as superposition of cosmids subcloned from the YAC or screened with the YAC as
probe. Vertical arrow marks cDNA probe name; ‘s’ character below the probe name indicates that the region corresponding to the probe is se-
quenced. If only one of the vector promoters was used to generate riboprobe, the name of the promoter is shown under the probe name. (+)
or (3) indicates positive or negative results of hybridization. Horizontal dot lines mark cosmids forming minimal tilling path. Shaded rectangle
marks the cosmids containing 13g3/CLL2-5 gene.
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2.3. FISH
Biotin labelled YAC or cosmid DNA to human chromosome meta-
phase spreads of the lymphoblastoid cell line ROM-2 in combination
with R^G banding was done as described by others [17].
2.4. Clone grid
High-density cosmid clone grids were used with each clone double
spotted. The grids were from ICRF (UK) and RZPD (DB) (36864
spots on 22U22-cm nylon membrane) or prepared in the study (1536
spots on 8U12-cm membrane) and processed as described earlier [18].
2.5. YAC probes
YAC probes for cosmid grid screening were prepared according to
[19] and labelled by random priming. End labelling and hybridization
of oligonucleotide probes to the cosmid grids were carried out as
described elsewhere [14], and positive cosmids were checked by South-
ern or PCR analysis.
2.6. Computer program
Computer program ‘Contig’ [20] was used for cosmid contig assem-
bly. The program is available via ftp://ftp.icnet.uk/icrf-public/Ge-
nomeAnalysis/icrf_contigv2.-tar.Z
3. Results
3.1. A cosmid sublibrary in the RB1-D13S25 region of
chromosome 13
Three YAC clones (CEPH745e3, ICRF 61c1 and
ICRF101d6) were used as probes for screening of the cosmid
library grids to ¢nd more than 400 clones belonging to the
region. We checked 95 cosmids randomly picked up from the
subset by FISH to human metaphase spread. Seventy-one of
the cosmids belonged to 13q14. Forty-eight out of the 71
cosmids had a unique location in the human genome. For
23 out of the 71 an additional location(s) in the human ge-
nome was found. Some double locations were found on chro-
mosome 13 (+13q12, +13q21, +13q34) including a double
signal in 13q14. The revealed high level of imperfect duplica-
tions involving the region indicates the need for caution in the
interpretation of further cDNA screening results and assign-
ment of DNA probes from the region.
3.2. A cosmid contig between loci D13S1168 and D13S25
As starting points for chromosome walking in the region we
used STS assigned cosmids in addition to FISH characterized
cosmids corresponding to both YAC CEPH 745e3 and ICRF
61c1. Riboprobes were generated from 172 individual cosmid
insert ends and hybridized to the cosmid subset representing
the 13q14 region or to the total chromosome 13 library grid.
The hybridization data gained with the riboprobes as well as
with 21 oligonucleotide probes for the STS and EST in the
region have been entered and interpreted by the ‘Contig’ com-
puter program. Though the region was mainly covered by the
LANL contigged cosmids after the subset analysis, we found
some gaps in the cosmid map and branching points. To bridge
the gaps we used a set of cosmids [10] prepared by subcloning
of YACs covering the region.
The resulting cosmid contig between loci D13S1168 and
D13S25 is presented in Fig. 1. Twelve EST and STS markers
have been assigned to the contigged cosmids. A minimal till-
ing path for the region can be formed of 19 LANL and ICRF
cosmids (marked with a horizontal dot line in Fig. 1). The
estimated total length of the contigged region is approxi-
mately 620 kb. Nucleotide sequences have been established
for some cosmid insert ends marked by the ‘s’ letter line in
Fig. 1. The complete information on the contig hybridization
and sequence data is available from N.Y.
3.3. cDNA library screening, characterization and mapping
In screening for cDNA clones we concentrated on the re-
gion between D13S273 and AFMA301wb5 which is the focus
of deletions associated with B-CLL [6,9,10]. Screening a pre-B
lymphocyte cDNA library was done with the labelled ICRF
YAC 61c1 (370 kb) bridging without gaps the interval be-
tween loci D13S1150 and D13S272 and nearly reaching AF-
MA301wb5 on the telomeric end (see Fig. 1). The YAC cor-
responds to the centromeric half of the region associated with
B-CLL deletions. Screening of placenta and fetal brain libra-
ries (Stratagene) was done with labelled fragments of cosmids
1a, 32a, 30a.
Five clones were isolated and one of them, 10k4 (1.4 kb in
size), was analyzed here. It appeared that this clone and
CLL2-5 gene, described in [11], contains the same sequences.
cDNA clone 10k4 contains an ORF coding for a protein of
407 amino acids. A middle part of the amino acid sequence
contains a zinc-¢nger domain of the RING type and shares
homology with some human transcription factors taking part
in early embryogenesis and tumor progression (Fig. 2). The
maximal homology (P-value = 1.8eÿ20) was shown for XPRF
transcription factor described in [22]. This protein is a product
of MID1 gene, which acts in early human embryogenesis and
is deleted in Opitz G/BBB syndrome (midline formation de-
fect). The gene is evolutionarily conserved as can be con-
cluded from a protein homology to A33 protein from ribbed
newt and to F54G8.4 protein from C. elegans (see Fig. 2).
Some of the proteins sharing homology to 10k4 are present
in human B-lymphocytes, which are the target cells for B-
CLL. These are transcription factors Rpt-1, Staf-50, and a
Sjoºgren syndrome antigen RO-SS/A. 10k4 also shares a ho-
mology with BRCA-1, which is a well established TSG. Beside
10k4 is the minimally deleted genome region shown for B-
CLL in our recent study [11]. That makes cDNA 10k4 a
probable candidate for B-CLL TSG.
Three cDNA clones have been found in the pre-B lympho-
cyte cDNA library. These are 13g1 (1.6 kb), 13g2 (2.7 kb),
and 13g3 (1.2 kb). Clones 13g1 and 13g2 contain a poly-A
tail. Northern analysis shows that 13g1 hybridizes to four
di¡erent bands corresponding to 1.3-, 1.6-, 2.9- and 3.5-kb
mRNA; 13g2 did not produce a clear Northern signal; 13g3
corresponds to 1.7-, 2.4-, and 7.5-kb mRNA.
All the cDNA clones have been sequenced. The sequence
analysis revealed that 13g3 cDNA contains sequences partly
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Fig. 2. Comparison of the predicted amino acid sequences of a
Leu5 zinc-¢nger domain fragment with database protein sequences.
Amino acid identities and conservative substitutions are shown in
bold. All protein sequences except Leu5 were retrieved from the
NCBI/GenBank database.
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overlapping with 10k4 (EMBL Acc. AJ224819) and CLL2-5
clones [11]. 13g3 cDNA had a homology to a number of
ESTs. These ESTs were also found homologous to 10k4
[11]. The cDNA sequence analysis shows that clone 13G1 is
virtually identical to p48/Hip (GenBank Acc. U28918) [21].
Clone 13g2 shows no clear homology in the GeneBank se-
quences, except for an Alu repeat presented in 13g2.
ESTs corresponding to 13g1, 13g2 and 10k4/13g3 cDNA
clones have been established. The primer structure and PCR
conditions are the following:
EST 13g1 is located between 206xf12 and D13S1269, and
EST 13g2 and 10k4/13g3 are located between D13S1168 and
D13S319 (see Fig. 1). The cDNA clones also have been
mapped against the cosmid panel by hybridization. cDNA
13g1 corresponds to cosmids 47g5 and 74d12; 13g2 corre-
sponds to cosmids 143g9, 170c7, 71a11 and 176c2. cDNA
10k4/13g3 corresponds to cosmids 6b11 and 67b4 (see Fig. 1).
4. Discussion
We have constructed a cosmid contig in the 13q14 region
between the RB1 gene and D13S25 locus, which is expected to
contain a putative B-CLL TSG [4^9]. We faced branching in
the left part of the contig covering 200 kb and presented by
¢ve-cosmid tilling path (122F4, 6b11, 162a3, 60a1, 71a11).
Indeed each of the cosmids has at least one more location
in the human genome according to FISH. Contig branching
was also shown in a study of chromosome 16 abnormalities in
acute non-lymphocytic leukemia [23]. This branching was due
to a chromosome 16 speci¢c repeat. Some sites of transloca-
tions and inversions in persons a¡ected by leukemia coincided
with the sites of the repeat location. It could also be a possible
explanation for B-CLL associated rearrangements found in
the 13q14 region [4^9].
In a previous study we found two genes (Leu1 and Leu2)
that span the minimally deleted region. Detailed mutational
analysis of these genes in a large B-CLL material, however,
did not reveal any cases with point mutations or small muta-
tions in any of these genes. It can therefore not be ruled out
that other adjacent or overlapping genes may be of impor-
tance. In the present study we describe three additional cDNA
clones that belong to three di¡erent loci on human chromo-
some 13 within the region of interest.
The distances between the loci are approximately 40 kb (see
Fig. 2). The cDNA clones likely correspond to three di¡erent
genes from their di¡erent location and according to the se-
quence and Northern hybridization data.
BLASTN and FASTA analysis of the sequence derived
from the 10k4 clone revealed that it is homologous to 15
clones from di¡erent libraries made from spleen, colon, pla-
centa as well as T and B lymphocytes. Each of these clones,
however, corresponds to short fragments of the 10k4 se-
quence. Interestingly, the deduced 10k4 protein sequence
shares signi¢cant homology to the RET ¢nger protein and
the well-known TSG BRCA1. Furthermore, 10k4 is bordering
the minimally deleted region at 13q described in a recent study
that we performed on 209 B-CLL clones [11]. Taking the data
together we believe that the gene corresponding to the 10k4
clone could be an additional interesting candidate for B-CLL
TSG. We have termed this gene as Leu5.
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